Who Paid My Doc
Novocart 3D
Device Cartilage Repair And Regeneration
General payments
$125,226
Research payments
$6,973,338
Through program year 2024, $125,226 in general payments and $6,973,338 in research payments were reported against Novocart 3D (Cartilage Repair And Regeneration).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $5,246 | 11 |
| 2024 | Research | $554,308 | 81 |
| 2023 | General | $4,718 | 31 |
| 2023 | Research | $1,179,131 | 143 |
| 2022 | General | $15,531 | 62 |
| 2022 | Research | $1,174,700 | 142 |
| 2021 | General | $31,243 | 70 |
| 2021 | Research | $1,713,281 | 262 |
| 2020 | General | $26,278 | 69 |
| 2020 | Research | $1,002,692 | 251 |
| 2019 | General | $42,211 | 170 |
| 2019 | Research | $1,349,225 | 279 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
413 general · 1,158 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.